期刊文献+

天然环酯肽Hikiamides A-C的全合成

Total synthesis of cyclodepsipeptide Hikiamides A-C
下载PDF
导出
摘要 设计完成了环酯肽类活性天然产物Hikiamides A-C的全合成:以市售氮端或羧基端保护的氨基酸为原料,采用片段汇聚式的液相缩合方法。首先,分别制备三肽片段(化合物5a/5b)和二肽片段(化合物8a/8b);然后,经过缩合、催化氢化得到直链五肽(化合物9a/9b/9c);最后,在混合缩合剂(Py BOP和HBTU)的作用下,关环得到Hikiamides A-C,总收率分别为9%、11%和6.5%。该液相全合成方法具有经济性强、操作简便,收率高等优点,有效解决了Hikiamides A-C天然来源获得性较差的问题。 Total synthesis of cyclodepsipeptide Hikiamides A-C was described.Fragment convergent condensation method was applied for the preparation of Hikiamides A-C,starting from Commercially available amino acid such as L-N-Boc-Phe-OH,L-N-Boc-Trp-OH,L-N-Cbz-Van-OH etc.Tripeptide fragments(compounds 5a/5b)and dipeptide fragments(compounds 8a/8b)were first prepared.The subsequent condensation of the resulted two fragments provided protected linear pentapetides(compounds 9a/9b/9c);Finally,the linear pentapetide was cyclized by a mixed condensing agents comprised of PyBOP and HBTU.Hikiamides A-C was obtained with total yields of 9%,11%and 6.5%,respectively.Compared with the natural source,this method has the advantages of low cost,convenient operation and high yield,which effectively solves the problem of low isolated yield of Hikiamides A-C from Fusarium sp.
作者 傅东林 饶雪敏 徐进宜 谢唯佳 吴晓明 FU Donglin;RAO Xuemin;XU Jinyi;XIE Weijia;WU Xiaoming(Institute of Pharmaceutical Science,China Pharmaceutical University,Nanjing 210009,China;Department of Medicinal Chemistry,China Pharmaceutical University,Nanjing 210009,China)
出处 《中国药科大学学报》 CAS CSCD 北大核心 2018年第2期181-186,共6页 Journal of China Pharmaceutical University
关键词 镰刀菌 环酯肽 Hikiamides A-C 过氧化物酶体增殖物激活受体 天然产物 全合成 Fusarium sp. cyclodepsipeptide Hikiamides A-C PPARγ natural products total synthesis
  • 相关文献

参考文献2

二级参考文献148

  • 1American Diabetes Association. Standards of medical care indiabetes--2009. Diabetes Care 2009; 32 Suppl 1: S13-S61 [PMID:19118286 DOI: 10.2337/dc09-S013].
  • 2Canadian Diabetes Association. 2008 clinical practice guidelinesfor the prevention and management of diabetes in Canada. Can JDiabetes 2008; 32 (suppl 1): S1-S201.
  • 3Hirst JE, Raynes-Greenow CH, Jeffery HE. A systematic reviewof trends of gestational diabetes mellitus in Asia. Journal ofDiabetology 2012; 3: 4.
  • 4Guariguata L, Linnenkamp U, Beagley J, Whiting DR, ChoNH. Global estimates of the prevalence of hyperglycaemia inpregnancy. Diabetes Res Clin Pract 2014; 103: 176-185 [PMID:24300020 DOI: 10.1016/j.diabres.2013.11.003].
  • 5American Diabetes Association. Standards of medical care indiabetes--2014. Diabetes Care 2014; 37 Suppl 1: S14-S80 [PMID:24357209 DOI: 10.2337/dc14-S014].
  • 6Yessoufou A, Moutairou K. Maternal diabetes in pregnancy:early and long-term outcomes on the offspring and the conceptof "metabolic memory". Exp Diabetes Res 2011; 2011: 218598[PMID: 22144985 DOI: 10.1155/2011/218598].
  • 7Mitanchez D. Foetal and neonatal complications in gestationaldiabetes: perinatal mortality, congenital malformations, macrosomia,shoulder dystocia, birth injuries, neonatal complications. DiabetesMetab 2010; 36: 617-627 [PMID: 21163425 DOI: 10.1016/j.diabet.2010.11.013].
  • 8Suhonen L, Hiilesmaa V, Kaaja R, Teramo K. Detection ofpregnancies with high risk of fetal macrosomia among women withgestational diabetes mellitus. Acta Obstet Gynecol Scand 2008; 87:940-945 [PMID: 18728914 DOI: 10.1080/00016340802334377].
  • 9Boney CM, Verma A, Tucker R, Vohr BR. Metabolic syndromein childhood: association with birth weight, maternal obesity, andgestational diabetes mellitus. Pediatrics 2005; 115: e290-e296[PMID: 15741354 DOI: 10.1542/peds.2004-1808].
  • 10Chiu M, Austin PC, Manuel DG, Shah BR, Tu JV. Derivingethnic-specific BMI cutoff points for assessing diabetes risk.Diabetes Care 2011; 34: 1741-1748 [PMID: 21680722 DOI:10.2337/dc10-2300].

共引文献56

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部